Andrew Saik

2020 - VYNE Therapeutics

In 2020, Andrew Saik earned a total compensation of $1.5M as Chief Financial Officer and Treasurer at VYNE Therapeutics.

Compensation breakdown

Bonus$112,500
Option Awards$470,315
Salary$309,722
Stock Awards$644,000
Total$1,536,537

Saik received $644K in stock awards, accounting for 42% of the total pay in 2020.

Saik also received $112.5K in bonus, $470.3K in option awards and $309.7K in salary.

Rankings

In 2020, Andrew Saik's compensation ranked 6,731st out of 13,090 executives tracked by ExecPay. In other words, Saik earned more than 48.6% of executives.

ClassificationRankingPercentile
All
6,731
out of 13,090
49th
Division
Manufacturing
2,802
out of 5,618
50th
Major group
Chemicals And Allied Products
1,131
out of 2,251
50th
Industry group
Drugs
975
out of 1,951
50th
Industry
Pharmaceutical Preparations
728
out of 1,456
50th
Source: SEC filing on June 7, 2021.

Saik's colleagues

We found three more compensation records of executives who worked with Andrew Saik at VYNE Therapeutics in 2020.

2020

David Domzalski

VYNE Therapeutics

Chief Executive Officer

2020

Steven Basta

VYNE Therapeutics

Chief Executive Officer

2020

Mutya Harsch

VYNE Therapeutics

Chief Legal Officer

News

You may also like